Literature DB >> 15339172

Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.

Abir L Banerjee1, Michael Swanson, Bidhan C Roy, Xiao Jia, Manas K Haldar, Sanku Mallik, D K Srivastava.   

Abstract

We elaborate on a novel strategy for enhancing the binding affinity of an active-site directed inhibitor by attaching a tether group, designed to interact with the surface-exposed histidine residue(s) of enzymes. In this approach, we have utilized the recombinant form of human carbonic anhydrase-II (hCA-II) as the enzyme source and benzenesulfonamide and its derivatives as inhibitors. The steady-state kinetic and the ligand binding data revealed that the attachment of iminodiacetate (IDA)-Cu(2+) to benzenesulfonamide (via a triethylene glycol spacer) enhanced its binding affinity for hCA-II by about 40-fold. No energetic contribution of either IDA or triethylene glycol spacer was found (at least in the ground state of the enzyme-inhibitor complex) when Cu(2+) was stripped off from the tether group-conjugated sulfonamide derivative. Arguments are presented that the overall strategy of enhancing the binding affinities of known inhibitors by attaching the IDA-Cu(2+) groups to interact with the surface-exposed histidine residues will find a general application in designing the isozyme-specific inhibitors as potential drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339172     DOI: 10.1021/ja047557p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  14 in total

1.  Ultrafast de novo docking combining pharmacophores and combinatorics.

Authors:  Marcus Gastreich; Markus Lilienthal; Hans Briem; Holger Claussen
Journal:  J Comput Aided Mol Des       Date:  2007-01-30       Impact factor: 3.686

Review 2.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

3.  Synthesis of barbiturate-based methionine aminopeptidase-1 inhibitors.

Authors:  Manas K Haldar; Michael D Scott; Nitesh Sule; D K Srivastava; Sanku Mallik
Journal:  Bioorg Med Chem Lett       Date:  2008-03-04       Impact factor: 2.823

Review 4.  Application of metal coordination chemistry to explore and manipulate cell biology.

Authors:  Kathryn L Haas; Katherine J Franz
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

5.  Influence of "Flexible" versus "Rigid" Nanoparticles on the Stability of Matrix Metalloproteinase-7.

Authors:  Bratati Ganguly; D K Srivastava
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

6.  Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I.

Authors:  Sumathra Manokaran; Jayati Banerjee; Sanku Mallik; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2010-07-08

7.  Differential modulation of the active site environment of human carbonic anhydrase XII by cationic quantum dots and polylysine.

Authors:  Sumathra Manokaran; Xing Zhang; Wei Chen; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2010-03-06

8.  Probing the metal ion selectivity in methionine aminopeptidase via changes in the luminescence properties of the enzyme bound europium ion.

Authors:  Nitesh Sule; Raushan K Singh; Pinjing Zhao; D K Srivastava
Journal:  J Inorg Biochem       Date:  2011-09-22       Impact factor: 4.155

9.  Alternative Modes of Binding of Recombinant Human Histone Deacetylase 8 to Colloidal Gold Nanoparticles.

Authors:  Nitesh Sule; Raushan Singh; D K Srivastava
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

10.  Selective protein-surface sensing using ruthenium(II) tris(bipyridine) complexes.

Authors:  James Muldoon; Alison E Ashcroft; Andrew J Wilson
Journal:  Chemistry       Date:  2010-01-04       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.